Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
According to my calculations from the most recent 10Q, they pass all the numerical CK criteria, other than near misses on the flow ratio.

Gross Margin -- 69.3%
Net Margin -- 17.5%
Leveraged Flow -- 1.56
Unleveraged Flow -- 1.75
Cash/Debt -- 2.69

Of all the medical companies out there, this one has the highest consumer mindshare. The margins on products like band aids and Tylenol may not be the best, but they certainly ensure that the company will make money year in and year out. They also have a healthy annual investment in R&D.

The stock's performance over the years certainly speaks for itself.

Personally, I like the direction as well. EPS has grown by more than 14% over the last 5 years and is expected to grow just over 13% over the next 5.

Biggest shortcomings of this one is that they need to do some work on their flow ratio.

Phil

Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.